Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 10/54
Thomas
Carper
U.S. Senate · D-DE
Taken from pharma & insurers
$118,709
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 10/54
Pharma & Health$98,900
Insurers & HMOs$19,809
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 10 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$118,709
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Through the leadership PAC
Beyond the campaign account, a leadership PAC under Carper's control (First State PAC) took $993,500 from banks, card lenders, drug makers and insurers.
Source: FEC; First State PAC
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
★ Hall of Shame
Carper voted with the money in more than one set:
Don't recognize a logo? Here's the key.
Pharma & Health$98,900
Johnson & Johnson$22,550
Amgen$16,900
PhRMA$14,500
Eli Lilly$14,200
Pfizer$14,100
Merck$13,650
Bristol Myers Squibb$3,000
Insurers & HMOs$19,809
Cigna$11,500
AHIP$8,000
Aetna$309